{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:42:12Z","timestamp":1792784532946,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Fondazione Cassa di Risparmio di Terni e Narni"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.urolonc.2017.08.004","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T21:01:52Z","timestamp":1504731712000},"page":"674.e19-674.e24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Characterization of inflammasome-related genes in urine sediments of patients receiving intravesical BCG therapy"],"prefix":"10.1016","volume":"35","author":[{"given":"Giulia","family":"Poli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Cochetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Boni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giulia","family":"Egidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Brancorsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Mearini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2017.08.004_bib1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1258\/j.jmb.2007.06-15","article-title":"Albert Calmette (1863\u20131933) and Camille Gu\u00e9rin (1872\u20131961). The C and G of BCG vaccine","volume":"15","author":"Hawgood","year":"2007","journal-title":"J Med Biogr"},{"key":"10.1016\/j.urolonc.2017.08.004_bib2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2017.08.004_bib3","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.juro.2007.09.003","article-title":"Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update","volume":"178","author":"Hall","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2017.08.004_bib4","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2013.06.003","article-title":"European Association of Urology. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013","volume":"64","author":"Babjuk","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2017.08.004_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/j.seminoncol.2006.12.004","article-title":"Immunotherapeutic strategies for high-risk bladder cancer","volume":"34","author":"Sharma","year":"2007","journal-title":"Semin Oncol"},{"key":"10.1016\/j.urolonc.2017.08.004_bib6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00299717","article-title":"BCG treatment and the importance of an inflammatory response","volume":"20","author":"Schamhart","year":"1992","journal-title":"Urol Res"},{"key":"10.1016\/j.urolonc.2017.08.004_bib7","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1464-410X.2012.11754.x","article-title":"Bacillus Calmette-Guerin immunotherapy for genitourinary cancer","volume":"112","author":"Gandhi","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2017.08.004_bib8","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1128\/iai.63.7.2652-2657.1995","article-title":"A Mycobacterium leprae gene encoding a fibronectin-binding protein is used for efficient invasion of epithelial cells and Schwann cells","volume":"63","author":"Schorey","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.urolonc.2017.08.004_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jtbi.2011.02.008","article-title":"A mathematical model of combined bacillus Calmette-Guerin (BCG) and interleukin (IL)-2 immunotherapy of superficial bladder cancer","volume":"277","author":"Bunimovich-Mendrazitsky","year":"2011","journal-title":"J Theor Biol"},{"key":"10.1016\/j.urolonc.2017.08.004_bib10","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1182\/blood-2005-03-1281","article-title":"Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes","volume":"106","author":"Abadie","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.urolonc.2017.08.004_bib11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2172-8-6","article-title":"Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)","volume":"8","author":"Saban","year":"2007","journal-title":"BMC Immunol"},{"key":"10.1016\/j.urolonc.2017.08.004_bib12","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.bjc.6602026","article-title":"Role of urothelial cells in BCG immunotherapy for superficial bladder cancer","volume":"91","author":"Bevers","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2017.08.004_bib13","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0022-5347(17)35678-1","article-title":"T-cell subsets required for intravesical BCG immunotherapy for bladder cancer","volume":"150","author":"Ratliff","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2017.08.004_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2217\/1750743X.1.2.281","article-title":"Bacillus Calmette\u2013Guerin immunotherapy for urothelial carcinoma of the bladder","volume":"1","author":"Kresowik","year":"2009","journal-title":"Immunotherapy"},{"key":"10.1016\/j.urolonc.2017.08.004_bib15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni.2224","article-title":"Inflammasomes in carcinogenesis and anticancer immune responses","volume":"13","author":"Zitvogel","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.urolonc.2017.08.004_bib16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1152\/physrev.00009.2014","article-title":"NOD-like receptors: versatile cytosolic sentinels","volume":"95","author":"Motta","year":"2015","journal-title":"Physiol Rev"},{"key":"10.1016\/j.urolonc.2017.08.004_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrm1019","article-title":"NALPs: a novel protein family involved in inflammation","volume":"4","author":"Tschopp","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.urolonc.2017.08.004_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1158\/2326-6066.CIR-16-0269","volume":"5","author":"Karki","year":"2017","journal-title":"Cancer Immunol Res."},{"key":"10.1016\/j.urolonc.2017.08.004_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2015.07.012","article-title":"Expression of inflammasome-related genes in bladder cancer and their association with cytokeratin 20 messenger RNA","volume":"33","author":"Poli","year":"2015","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2017.08.004_bib20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0302-2838(03)00357-9","article-title":"Maintenance Bacillus Calmette-Guerin for Ta T1 bladder tumors is not associated with increased toxicity: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial","volume":"44","author":"van der Meijden","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2017.08.004_bib21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ni.2239","article-title":"NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4","volume":"13","author":"Cui","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.urolonc.2017.08.004_bib22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.urolonc.2017.08.004_bib23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","volume":"13","author":"Latz","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.urolonc.2017.08.004_bib24","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.urolonc.2017.08.004_bib25","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3892\/ol.2013.1150","article-title":"Expression of the IAP protein family acts cooperatively to predict prognosis in human bladder cancer patients","volume":"5","author":"Chen","year":"2013","journal-title":"Oncol Lett"},{"key":"10.1016\/j.urolonc.2017.08.004_bib26","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/eji.201141548","article-title":"Activation of the NLRP3 inflammasome by Mycobacterium tuberculosis is uncoupled from susceptibility to active tuberculosis","volume":"42","author":"Dorhoi","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.urolonc.2017.08.004_bib27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.urolonc.2017.08.004_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/onc.2015.99","article-title":"Emerging strategies to effectively target autophagy in cancer","volume":"35","author":"Rebecca","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2017.08.004_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1172\/JCI73942","article-title":"Autophagy in cellular metabolism and cancer","volume":"125","author":"Jiang","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.urolonc.2017.08.004_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nm.1928","article-title":"Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells","volume":"15","author":"Jagannath","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.urolonc.2017.08.004_bib31","doi-asserted-by":"crossref","first-page":"e1004485","DOI":"10.1371\/journal.ppat.1004485","article-title":"Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer","volume":"10","author":"Buffen","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.urolonc.2017.08.004_bib32","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.4049\/jimmunol.1001654","article-title":"NLRP4 negatively regulates autophagic processes through an association with beclin1","volume":"186","author":"Jounai","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.urolonc.2017.08.004_bib33","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/cr.2007.78","article-title":"Physiological functions of Atg6\/Beclin 1: a unique autophagy-related protein","volume":"17","author":"Cao","year":"2007","journal-title":"Cell Research"},{"key":"10.1016\/j.urolonc.2017.08.004_bib34","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1442-2042.2010.02584.x","article-title":"BCG Tokyo Strain Study Group. Maintenance intravesical bacillus Calmette-Gu\u00e9rin instillation for Ta, T1 cancer and carcinoma in situ of the bladder: randomized controlled trial by the BCG Tokyo Strain Study Group","volume":"17","author":"Koga","year":"2010","journal-title":"Int J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143917304118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143917304118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:12:12Z","timestamp":1761041532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143917304118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1078143917304118"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2017.08.004","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of inflammasome-related genes in urine sediments of patients receiving intravesical BCG therapy","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2017.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}